110 related articles for article (PubMed ID: 8752172)
1. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor.
Hongo A; Yumet G; Resnicoff M; Romano G; O'Connor R; Baserga R
Cancer Res; 1998 Jun; 58(11):2477-84. PubMed ID: 9622092
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
Resnicoff M; Abraham D; Yutanawiboonchai W; Rotman HL; Kajstura J; Rubin R; Zoltick P; Baserga R
Cancer Res; 1995 Jun; 55(11):2463-9. PubMed ID: 7758000
[TBL] [Abstract][Full Text] [Related]
5. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
Chen H; Yan GC; Gishizky ML
Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
[TBL] [Abstract][Full Text] [Related]
6. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
7. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
8. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
9. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.
Resnicoff M; Burgaud JL; Rotman HL; Abraham D; Baserga R
Cancer Res; 1995 Sep; 55(17):3739-41. PubMed ID: 7641185
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of ethanol on insulin-like growth factor-I receptor signaling.
Seiler AE; Ross BN; Green JS; Rubin R
Alcohol Clin Exp Res; 2000 Feb; 24(2):140-8. PubMed ID: 10698364
[TBL] [Abstract][Full Text] [Related]
11. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
12. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
13. Activation of pro-apoptotic p38-MAPK pathway in the prostate cancer cell line M12 expressing a truncated IGF-IR.
Wu J; Haugk K; Plymate SR
Horm Metab Res; 2003; 35(11-12):751-7. PubMed ID: 14710354
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
[TBL] [Abstract][Full Text] [Related]
15. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
16. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
Rubin R; Baserga R
Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
[TBL] [Abstract][Full Text] [Related]
18. The IGF-I receptor protects tumor cells from apoptosis induced by high concentrations of serum.
Valentinis B; Baserga R
Biochem Biophys Res Commun; 1996 Jul; 224(2):362-8. PubMed ID: 8702396
[TBL] [Abstract][Full Text] [Related]
19. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death.
Wu Y; Tewari M; Cui S; Rubin R
J Cell Physiol; 1996 Sep; 168(3):499-509. PubMed ID: 8816904
[TBL] [Abstract][Full Text] [Related]
20. Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.
Stewart CE; Newcomb PV; Savage PB; Dickens M; Tavare J; Holly JM
Growth Horm IGF Res; 1999 Apr; 9(2):131-42. PubMed ID: 10373346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
